2Performance standards for antimicrobial susceptibility testing:Nine- teenth Informational Supplement. Clinical and Laboratory Stand- ards Institute (CLSI) document M 100-S 19 [ R ]. Wayne, PA : Clini- cal and Laboratory Standards Institute ;2009,29 (3) :34 - 38.
3Ling J, Chan E, Lain A, et al. Mutations in topoisomerase genes of fluoroquinolone-resistant Salmonellae in Hong Kong [ J]. Antimi- crobial Agents and Chemotherapy,2003,47( 11 ) :3567 -3573.
4Dias de Oliveira S ,Siqueira Flores F,Dos Santos L,et al. Antimi- crobial resistance in Salmonella enteritidis strains isolated from broiler carcasses, food, human and poultry-related samples[ J]. In- ternational Journal of Food Microbiology, 2005,97 ( 3 ) : 297 - 305.
5lzumiya H, Mori K, Kurazono T, et al. Characterization of isolates of Salmonella enterica serovar Typhimurium displaying high-level fluoroquinolone resistance in Japan[ J]. Journal of Clinical Micro- biology ,2005,43 (10) :5074 - 5079.
6Hirose K, Hashimoto A, Tamura K, et al. DNA sequence analysis of DNA gyrase and DNA topoisomerase IV quinolone resistance- determining regions of Salmonella enterica serovar and serovar Paratyphi A [ J ]. Antimicrobial Agents and Chemotherapy,2002, 46(10) :3249 -3252.
7Eaves D,Liebana E,Woodward M,et al. Detection of gyrA muta- tions in quinolone-resistant Salmonella enterica by denaturing high-performance liquid chromatography [ J ]. Journal of Clinical Microbiology ,2002,40( 11 ) :4121 -4125.
8Levy D, Sharma B, Cebula T. Single-nucleotide polymorphism mutation spectra and resistance to quinolones in Salmonella enterica serovar Enteritidis with a mutator phenotype [ J ]. Antimicrobial Agents and Chemotherapy,2004,48 (7) :2355 - 2363.
9Baucheron S,Chaslus-Dancla E, Cloeekaert A, et al. High-level resistance to fluoroquinolones finked to mutations in gyrA,parC, and parE in Salmonella enterica serovar Schwarzengrund isolates from humans in Taiwan[ J]. Antimicrobial Agents and Chemo- therapy,2005,49 (2) : 862 - 862.
10Casin I,Breuil J, Darchis J, et al. Fluoroquinolone resistance linked to GyrA, GyrB, and ParC mutations in Salmonella enterica T xphimurium isolates in humans [ J ]. Emerging Infectious Disea- ses,2003,9(11 ) :1455 - 1457.
